 |
Previous Article | Next Article 
Journal of Neuroscience, Vol 14, 134-139, Copyright © 1994 by Society for Neuroscience
Extracellular cGMP in the hippocampus of freely moving rats as an index of nitric oxide (NO) synthase activity
F Vallebuona and M Raiteri
Institute of Pharmacology and Pharmacognosy, University of Genova, Italy.
The nitric oxide (NO) synthase/cGMP pathway has been studied in vivo in the
adult rat hippocampus by monitoring the levels of extracellular cGMP during
microdialysis in conscious unrestrained animals. The basal cGMP efflux was
concentration-dependently reduced upon local infusion of the NO synthase
inhibitor NG-nitro-L-arginine (NARG; 10 microM to 1 mM). The NO donors
hydroxylamine and S-nitroso-N-penicillamine, perfused through the dialysis
probe at 1 mM, increased by about 200% the extracellular levels of cGMP.
The glutamate receptor agonist NMDA (125-500 microM) produced
concentration-dependent cGMP responses that were abolished by the selective
receptor antagonist D-2-amino-5- phosphonovaleric acid or by NARG. Local
perfusion of the phosphodiesterase inhibitor 3-isobutyl-1-methylxanthine
(IBMX; 1 mM) produced a steady eightfold increase of extracellular cGMP
levels. The effect of IBMX was highly sensitive to NARG. The inhibition by
NARG of the IBMX-induced cGMP response was reversed when the NO synthase
substrate L-arginine was administered. It is concluded that cGMP collected
during in vivo microdialysis reflects NO synthase activity in the rat
hippocampus. The technique may be utilized to investigate the
pathophysiology and the pharmacology of the NO/cGMP pathway in the
hippocampus of living animals.
This article has been cited by other articles:

|
 |

|
 |
 
N. U. Suvarna and J. M. O'Donnell
Hydrolysis of N-Methyl-D-aspartate Receptor-Stimulated cAMP and cGMP by PDE4 and PDE2 Phosphodiesterases in Primary Neuronal Cultures of Rat Cerebral Cortex and Hippocampus
J. Pharmacol. Exp. Ther.,
July 1, 2002;
302(1):
249 - 256.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Goyagi, S. Goto, A. Bhardwaj, V. L. Dawson, P. D. Hurn, and J. R. Kirsch
Neuroprotective Effect of {{sigma}}1-Receptor Ligand 4-Phenyl-1-(4-Phenylbutyl) Piperidine (PPBP) Is Linked to Reduced Neuronal Nitric Oxide Production
Stroke,
July 1, 2001;
32(7):
1613 - 1620.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. Lindauer, D. Megow, H. Matsuda, and U. Dirnagl
Nitric oxide: a modulator, but not a mediator, of neurovascular coupling in rat somatosensory cortex
Am J Physiol Heart Circ Physiol,
August 1, 1999;
277(2):
H799 - H811.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Bhardwaj, M. Sawada, E. D. London, R. C. Koehler, R. J. Traystman, J. R. Kirsch, and F. M. Faraci
Potent {varsigma}1-Receptor Ligand 4-Phenyl-1-(4-Phenylbutyl) Piperidine Modulates Basal and N-Methyl-D-Aspartate–Evoked Nitric Oxide Production In Vivo • Editorial Comment
Stroke,
November 1, 1998;
29(11):
2404 - 2411.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Poulopoulou and L. M. Nowak
Extracellular 3',5' Cyclic Guanosine Monophosphate Inhibits Kainate-Activated Responses in Cultured Mouse Cerebellar Neurons
J. Pharmacol. Exp. Ther.,
July 1, 1998;
286(1):
99 - 109.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
G. Yang, C. Iadecola, and F. M. Faraci
Activation of Cerebellar Climbing Fibers Increases Cerebellar Blood Flow : Role of Glutamate Receptors, Nitric Oxide, and cGMP • Editorial Comment: Role of Glutamate Receptors, Nitric Oxide, and cGMP
Stroke,
February 1, 1998;
29(2):
499 - 508.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Pu, T. L. Horvath, S. Diano, F. Naftolin, P. S. Kalra, and S. P. Kalra
Evidence Showing That {beta}-Endorphin Regulates Cyclic Guanosine 3',5'-Monophosphate (cGMP) Efflux: Anatomical and Functional Support for an Interaction between Opiates and Nitric Oxide
Endocrinology,
April 1, 1997;
138(4):
1537 - 1543.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Williams, S. R. Vincent, and P. B. Reiner
Nitric Oxide Production in Rat Thalamus Changes with Behavioral State, Local Depolarization, and Brainstem Stimulation
J. Neurosci.,
January 1, 1997;
17(1):
420 - 427.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|

|